These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12011456)

  • 21. Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice.
    Muhammad N; Murakami T; Inoshima Y; Ishiguro N
    Clin Exp Immunol; 2015 Jul; 181(1):133-41. PubMed ID: 25736960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid membranes accelerate amyloid formation in the mouse model of AA amyloidosis.
    Vahdat Shariat Panahi A; Hultman P; Öllinger K; Westermark GT; Lundmark K
    Amyloid; 2019 Mar; 26(1):34-44. PubMed ID: 30929476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceleration of murine AA amyloid deposition by bovine amyloid fibrils and tissue homogenates.
    Cui D; Kawano H; Hoshii Y; Liu Y; Ishihara T
    Amyloid; 2008 Jun; 15(2):77-83. PubMed ID: 18484333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid-enhancing factor: production and response in amyloidosis-susceptible and -resistant mouse strains.
    Gervais F; Hébert L; Skamene E
    J Leukoc Biol; 1988 Apr; 43(4):311-6. PubMed ID: 3162509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review. Reflections on amyloidosis in Papua New Guinea.
    Westermark P; Westermark GT
    Philos Trans R Soc Lond B Biol Sci; 2008 Nov; 363(1510):3701-5. PubMed ID: 18849285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion-like aggregates: infectious agents in human disease.
    Westermark GT; Westermark P
    Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation.
    Shirahama T; Miura K; Ju ST; Kisilevsky R; Gruys E; Cohen AS
    Lab Invest; 1990 Jan; 62(1):61-8. PubMed ID: 2296158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmissibility of mouse AApoAII amyloid fibrils: inactivation by physical and chemical methods.
    Zhang H; Sawashita J; Fu X; Korenaga T; Yan J; Mori M; Higuchi K
    FASEB J; 2006 May; 20(7):1012-4. PubMed ID: 16549653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibril amyloid enhancing factor (FAEF)-accelerated amyloidosis in the hamster is not dependent on serine esterase activity and mononuclear phagocytosis.
    Niewold TA; Gruys E; Kisilevsky R; Shirahama TS
    Scand J Immunol; 1991 Jul; 34(1):101-7. PubMed ID: 2068530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggregation of Mouse Serum Amyloid A Protein Was Promoted by Amyloid-Enhancing Factors with the More Genetically Homologous Serum Amyloid A.
    Lin X; Watanabe K; Kuragano M; Tokuraku K
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and propagation of amyloid-enhancing factor.
    Kisilevsky R
    Methods Mol Biol; 2005; 299():237-41. PubMed ID: 15980607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diet, amyloid enhancing factor (AEF) and amyloidogenesis: an hypothesis.
    Cathcart ES; Elliott-Bryant R
    Amyloid; 1999 Jun; 6(2):107-13. PubMed ID: 10439116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species.
    Cui D; Kawano H; Takahashi M; Hoshii Y; Setoguchi M; Gondo T; Ishihara T
    Pathol Int; 2002 Jan; 52(1):40-5. PubMed ID: 11940205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model.
    Westermark P; Lundmark K; Westermark GT
    PLoS One; 2009 Jun; 4(6):e6041. PubMed ID: 19582162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceleration of murine amyloidosis by implantation of amyloid-containing grafts.
    Ono S; Cui D; Kunitsugu I; Hoshii Y; Kawano H; Takahashi M; Gondo T; Ishihara T
    Amyloid; 2005 Dec; 12(4):226-32. PubMed ID: 16399647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal study of experimental induction of AA amyloidosis in mice seeded with homologous and heterologous AA fibrils.
    Muhammad N; Murakami T; Inoshima Y; Ishiguro N
    Inflamm Res; 2016 Sep; 65(9):689-99. PubMed ID: 27165856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.